Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Arterial Stiffness and Blood Pressure in Patients Newly Diagnosed with Graves' Disease Compared with Euthyroid Controls.

European thyroid journal

Grove-Laugesen D, Malmstroem S, Ebbehoj E, Riis AL, Watt T, Rejnmark L, Würgler Hansen K.
PMID: 32523891
Eur Thyroid J. 2020 May;9(3):148-156. doi: 10.1159/000505873. Epub 2020 Feb 14.

INTRODUCTION AND OBJECTIVE: The excess cardiovascular morbidity and mortality in hyperthyroidism and Graves' disease (GD) is inadequately understood. We aimed to elucidate whether well-established cardiovascular risk factors such as arterial stiffness in terms of pulse wave velocity (PWV) and...

Cite
Grove-Laugesen D, Malmstroem S, Ebbehoj E, et al. Arterial Stiffness and Blood Pressure in Patients Newly Diagnosed with Graves' Disease Compared with Euthyroid Controls. Eur Thyroid J. 2020;9(3):148-156doi: 10.1159/000505873.
Grove-Laugesen, D., Malmstroem, S., Ebbehoj, E., Riis, A. L., Watt, T., Rejnmark, L., & Würgler Hansen, K. (2020). Arterial Stiffness and Blood Pressure in Patients Newly Diagnosed with Graves' Disease Compared with Euthyroid Controls. European thyroid journal, 9(3), 148-156. https://doi.org/10.1159/000505873
Grove-Laugesen, Diana, et al. "Arterial Stiffness and Blood Pressure in Patients Newly Diagnosed with Graves' Disease Compared with Euthyroid Controls." European thyroid journal vol. 9,3 (2020): 148-156. doi: https://doi.org/10.1159/000505873
Grove-Laugesen D, Malmstroem S, Ebbehoj E, Riis AL, Watt T, Rejnmark L, Würgler Hansen K. Arterial Stiffness and Blood Pressure in Patients Newly Diagnosed with Graves' Disease Compared with Euthyroid Controls. Eur Thyroid J. 2020 May;9(3):148-156. doi: 10.1159/000505873. Epub 2020 Feb 14. PMID: 32523891; PMCID: PMC7265727.
Copy Download .nbib Format: NLM
Effect of daily Vitamin D3 Supplementation on Muscle Health: An Individual Participant Meta-Analysis.

The Journal of clinical endocrinology and metabolism

Bislev LS, Wamberg L, Rolighed L, Grove-Laugesen D, Rejnmark L.
PMID: 35018442
J Clin Endocrinol Metab. 2022 Jan 08; doi: 10.1210/clinem/dgac004. Epub 2022 Jan 08.

BACKGROUND: The role of vitamin D on muscle health is debated.METHODS: An individual participant metanalysis of four randomized placebo-controlled trials, investigating short term (three to nine months) effects of vitamin D3 in moderate (2800 IU) to high (7000 IU)...

Cite
Bislev LS, Wamberg L, Rolighed L, et al. Effect of daily Vitamin D3 Supplementation on Muscle Health: An Individual Participant Meta-Analysis. J Clin Endocrinol Metab. 2022;doi: 10.1210/clinem/dgac004.
Bislev, L. S., Wamberg, L., Rolighed, L., Grove-Laugesen, D., & Rejnmark, L. (2022). Effect of daily Vitamin D3 Supplementation on Muscle Health: An Individual Participant Meta-Analysis. The Journal of clinical endocrinology and metabolism, . https://doi.org/10.1210/clinem/dgac004
Bislev, Lise Sofie, et al. "Effect of daily Vitamin D3 Supplementation on Muscle Health: An Individual Participant Meta-Analysis." The Journal of clinical endocrinology and metabolism vol. (2022). doi: https://doi.org/10.1210/clinem/dgac004
Bislev LS, Wamberg L, Rolighed L, Grove-Laugesen D, Rejnmark L. Effect of daily Vitamin D3 Supplementation on Muscle Health: An Individual Participant Meta-Analysis. J Clin Endocrinol Metab. 2022 Jan 08; doi: 10.1210/clinem/dgac004. Epub 2022 Jan 08. PMID: 35018442.
Copy Download .nbib Format: NLM
Three-year successful cinacalcet treatment of secondary hyperparathyroidism in a patient with x-linked dominant hypophosphatemic rickets: a case report.

Case reports in endocrinology

Grove-Laugesen D, Rejnmark L.
PMID: 24660072
Case Rep Endocrinol. 2014;2014:479641. doi: 10.1155/2014/479641. Epub 2014 Feb 10.

Hypophosphatemic rickets (HR) is a rare inherited disorder characterized by a classic rickets phenotype with low plasma phosphate levels and resistance to treatment with vitamin D. Development of secondary hyperparathyroidism (SHPT) as a direct consequence of treatment is a...

Cite
Grove-Laugesen D, Rejnmark L. Three-year successful cinacalcet treatment of secondary hyperparathyroidism in a patient with x-linked dominant hypophosphatemic rickets: a case report. Case Rep Endocrinol. 2014;2014:479641doi: 10.1155/2014/479641.
Grove-Laugesen, D., & Rejnmark, L. (2014). Three-year successful cinacalcet treatment of secondary hyperparathyroidism in a patient with x-linked dominant hypophosphatemic rickets: a case report. Case reports in endocrinology, 2014479641. https://doi.org/10.1155/2014/479641
Grove-Laugesen, Diana, and Rejnmark, Lars. "Three-year successful cinacalcet treatment of secondary hyperparathyroidism in a patient with x-linked dominant hypophosphatemic rickets: a case report." Case reports in endocrinology vol. 2014 (2014): 479641. doi: https://doi.org/10.1155/2014/479641
Grove-Laugesen D, Rejnmark L. Three-year successful cinacalcet treatment of secondary hyperparathyroidism in a patient with x-linked dominant hypophosphatemic rickets: a case report. Case Rep Endocrinol. 2014;2014:479641. doi: 10.1155/2014/479641. Epub 2014 Feb 10. PMID: 24660072; PMCID: PMC3934321.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries